Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Verrica Pharmaceuticals buy Brookline Capital Management

Verrica Pharmaceuticals
Start price
€0.58
18.12.25 / 50%
Target price
€14.48
18.12.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 18.12.26. The prediction end date can be changed by Brookline_Capital_Ma at any time.
Performance without dividends (%)
Name 1w
Verrica Pharmaceuticals -
iShares Core DAX® 3.002%
iShares Nasdaq 100 2.966%
iShares Nikkei 225® 5.606%
iShares S&P 500 2.312%

Comments by Brookline_Capital_Ma for this prediction

In the thread Discuss Verrica Pharmaceuticals
Prediction Buy
Perf. (%) -
Target price 14.482
Change
Ends at 18.12.26

Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Brookline Capital Management from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat

Brookline Capital Management 
0
Report Share
18.12.25